Immunity to malaria: more questions than answers

Malaria is one of the main health problems facing developing countries today. At present, preventative and treatment strategies are continuously hampered by the issues of the ever-emerging parasite resistance to newly introduced drugs, considerable costs and logistical problems. The main hope for changing this situation would be the development of effective malaria vaccines. An important part of this process is understanding the mechanisms of naturally acquired immunity to malaria. This review will highlight key aspects of immunity to malaria, about which surprisingly little is known and which will prove critical in the search for effective malaria vaccines.

[1]  L. H. Carvalho,et al.  IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites , 2005, The Journal of experimental medicine.

[2]  T. Daly,et al.  Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. , 1998, Journal of immunology.

[3]  C. Coban,et al.  Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.

[4]  E. Riley,et al.  Innate immunity to malaria , 2004, Nature Reviews Immunology.

[5]  G. McFadden,et al.  Inhibition of Dendritic Cell Maturation by Malaria Is Dose Dependent and Does Not Require Plasmodium falciparum Erythrocyte Membrane Protein 1 , 2007, Infection and Immunity.

[6]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.

[7]  Ana Rodriguez,et al.  Malaria Blood Stage Suppression of Liver Stage Immunity by Dendritic Cells , 2003, The Journal of experimental medicine.

[8]  A. Boonstra,et al.  Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells , 2006, The Journal of experimental medicine.

[9]  Danny W. Wilson,et al.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum , 2002, The Lancet.

[10]  S. Akira,et al.  Induction of Proinflammatory Responses in Macrophages by the Glycosylphosphatidylinositols of Plasmodium falciparum , 2005, Journal of Biological Chemistry.

[11]  J. Tavernier,et al.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. , 1987, Clinical and experimental immunology.

[12]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[13]  I. Clark.  DOES ENDOTOXIN CAUSE BOTH THE DISEASE AND PARASITE DEATH IN ACUTE MALARIA AND BABESIOSIS? , 1978, The Lancet.

[14]  J. Langhorne,et al.  Insights into the immunopathogenesis of malaria using mouse models , 2006, Expert Reviews in Molecular Medicine.

[15]  A. Holder,et al.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies , 1990, The Journal of experimental medicine.

[16]  A. Bossowski,et al.  [The role of T-regulatory cells in the pathogenesis of immunological disturbances accompanying obesity and atherosclerosis]. , 2010, Postepy higieny i medycyny doswiadczalnej.

[17]  Daniel J. Gaffney,et al.  Virulence in rodent malaria: host genotype by parasite genotype interactions. , 2002, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[18]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[19]  D. Conway,et al.  IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life , 2007, Malaria Journal.

[20]  E. Riley,et al.  Pathology of Plasmodium chabaudi chabaudi Infection and Mortality in Interleukin-10-Deficient Mice Are Ameliorated by Anti-Tumor Necrosis Factor Alpha and Exacerbated by Anti-Transforming Growth Factor β Antibodies , 2003, Infection and Immunity.

[21]  D. Golenbock,et al.  MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. , 2007, Microbes and infection.

[22]  R. Ahmed,et al.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation , 2003, Nature Immunology.

[23]  G. Awandare,et al.  Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. , 2006, The Journal of infectious diseases.

[24]  G. Freeman,et al.  Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression , 2006, Journal of Virology.

[25]  K. Marsh,et al.  Immune effector mechanisms in malaria , 2006, Parasite immunology.

[26]  M. Gatton,et al.  Characterization of the Antibody Response against Plasmodium falciparum Erythrocyte Membrane Protein 1 in Human Volunteers , 2007, Infection and Immunity.

[27]  L. Bruce-Chwatt.  A LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS. , 1963, The West African medical journal.

[28]  A. Holder,et al.  The Importance of Human FcγRI in Mediating Protection to Malaria , 2007, PLoS pathogens.

[29]  Jackie Williams,et al.  Protracted Protection to Plasmodium berghei Malaria Is Linked to Functionally and Phenotypically Heterogeneous Liver Memory CD8+ T Cells1 , 2003, The Journal of Immunology.

[30]  J. Koella,et al.  Host genotype by parasite genotype interactions underlying the resistance of anopheline mosquitoes to Plasmodium falciparum , 2005, Malaria Journal.

[31]  M. Good,et al.  Plasmodium yoelii Can Ablate Vaccine-Induced Long-Term Protection in Mice1 , 2005, The Journal of Immunology.

[32]  J. Sacci,et al.  CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes , 2007, Nature Medicine.

[33]  M. Dziegiel,et al.  A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII1 , 2007, The Journal of Immunology.

[34]  E. Riley,et al.  Differential Induction of TGF-β Regulates Proinflammatory Cytokine Production and Determines the Outcome of Lethal and Nonlethal Plasmodium yoelii Infections 1 , 2003, The Journal of Immunology.

[35]  安達 圭志.  Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism , 2003 .

[36]  M. Moran,et al.  The malaria product pipeline: planning for the future , 2007 .

[37]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[38]  N. Willcox,et al.  A role for CD36 in the regulation of dendritic cell function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[40]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[41]  K. Bussell.  Post-translational modification: Jack of all trades , 2005, Nature Reviews Molecular Cell Biology.

[42]  J. Langhorne,et al.  Cytokine responses of CD4+ T cells during a Plasmodium chabaudi chabaudi (ER) blood-stage infection in mice initiated by the natural route of infection , 2007, Malaria Journal.

[43]  C. Chougnet,et al.  Is immunity to malaria really short-lived? , 1992, Parasitology today.

[44]  M. Good,et al.  Systemic Tumor Necrosis Factor Generated during Lethal Plasmodium Infections Impairs Dendritic Cell Function1 , 2007, The Journal of Immunology.

[45]  J. Langhorne,et al.  Malarial anemia: of mice and men. , 2007, Blood.

[46]  Kenneth G. C. Smith,et al.  FcγRIIb controls bone marrow plasma cell persistence and apoptosis , 2007, Nature Immunology.

[47]  J. Langhorne,et al.  Longevity of the immune response and memory to blood-stage malaria infection. , 2005, Current topics in microbiology and immunology.

[48]  D. Kioussis,et al.  Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. , 2005, Blood.

[49]  Sankar Ghosh,et al.  Recognition and signaling by toll-like receptors. , 2006, Annual review of cell and developmental biology.

[50]  V. Nussenzweig,et al.  γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.

[51]  D. Parzy,et al.  Description of three new polymorphisms in the intronic and 3′UTR regions of the human interferon gamma gene , 2002, Genes and Immunity.

[52]  Ching Li,et al.  A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.

[53]  R. Schumann,et al.  Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. , 2006, The Journal of communicable diseases.

[54]  R. Abe,et al.  Swift Development of Protective Effector Functions in Naive Cd8+ T Cells against Malaria Liver Stages , 2001, The Journal of experimental medicine.

[55]  O. Doumbo,et al.  Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium falciparum Malaria and Matched Uncomplicated Malaria or Healthy Controls , 2004, Infection and Immunity.

[56]  R. Snow,et al.  Indicators of life-threatening malaria in African children. , 1995, The New England journal of medicine.

[57]  S. Akira,et al.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.

[58]  P. Taylor,et al.  Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudiParasites , 2001, Infection and Immunity.

[59]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[60]  P. Kremsner,et al.  Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I , 2003, Immunogenetics.

[61]  T. Nebl,et al.  Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors , 2005, Parasitology.

[62]  M. Veldhoen,et al.  TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells. , 2006, Trends in immunology.

[63]  J. Langhorne,et al.  Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi , 2001, European journal of immunology.

[64]  C. Newbold,et al.  CD4 T Cells from Malaria-Nonexposed Individuals Respond to the CD36-Binding Domain of Plasmodium falciparum Erythrocyte Membrane Protein-1 via an MHC Class II-TCR-Independent Pathway1 , 2006, The Journal of Immunology.

[65]  Patricia De la Vega,et al.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.

[66]  A. Sabchareon,et al.  Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. , 1991, The American journal of tropical medicine and hygiene.

[67]  A. Azad,et al.  Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  B. Ryffel,et al.  Murine cerebral malaria development is independent of toll-like receptor signaling. , 2007, The American journal of pathology.

[69]  M. Ciucă,et al.  Immunity in malaria , 1934 .

[70]  Apoorva Mandavilli,et al.  Of mice and men , 2006, Nature Medicine.

[71]  S. Hoffman,et al.  Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. , 2001, The American journal of tropical medicine and hygiene.

[72]  V. Adabayeri,et al.  Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria , 1998, The Lancet.

[73]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[74]  O. Skorokhod,et al.  Hemozoin (Malarial Pigment) Inhibits Differentiation and Maturation of Human Monocyte-Derived Dendritic Cells: A Peroxisome Proliferator-Activated Receptor-γ-Mediated Effect1 , 2004, The Journal of Immunology.

[75]  C. Akdis,et al.  Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells , 2006, Immunology.

[76]  R. May,et al.  Implications for Vaccine Development and Other Carbohydrates : neoformans Cryptococcus Polysaccharide Capsule of Cross-React with an Epitope on the Antibodies to Keyhole Limpet Hemocyanin , 2003 .

[77]  L. H. Carvalho,et al.  IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages , 2002, Nature Medicine.

[78]  J. Andersen,et al.  TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein , 2005, Science.

[79]  D. Baruch,et al.  Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[80]  K. Foulds,et al.  Th1 memory: implications for vaccine development , 2006, Immunological reviews.

[81]  J. Hittner,et al.  Disorders of Erythropoiesis • Brief Report Suppression of RANTES in children with Plasmodium falciparum malaria Tom , 2022 .

[82]  M. Cetron,et al.  Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. , 2000, The American journal of tropical medicine and hygiene.

[83]  P. Cazenave,et al.  Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. , 2006, The Journal of infectious diseases.

[84]  P. Kaye,et al.  Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria , 2002, The Journal of experimental medicine.

[85]  M. Molyneux,et al.  Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection , 2004, The Lancet.

[86]  T. Ottenhoff,et al.  Is there a future for TNF promoter polymorphisms? , 2004, Genes and Immunity.

[87]  D. Kwiatkowski,et al.  Tumour necrosis factor, fever and fatality in falciparum malaria. , 1990, Immunology letters.

[88]  Thomas Hartung,et al.  CD36 is a sensor of diacylglycerides , 2005, Nature.

[89]  M. Good,et al.  Interactions between malaria parasites and the host immune system. , 2005, Current opinion in immunology.

[90]  A. Antinori,et al.  The Cytokine Balance in Severe Malarial Anemia , 2010 .

[91]  M. Boivin,et al.  Low levels of RANTES are associated with mortality in children with cerebral malaria. , 2006, The Journal of infectious diseases.

[92]  Andrea Crisanti,et al.  Profiling the antibody immune response against blood stage malaria vaccine candidates. , 2007, Clinical chemistry.

[93]  R. Snow,et al.  The past, present and future of childhood malaria mortality in Africa. , 2001, Trends in parasitology.

[94]  C. Chougnet,et al.  Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. , 1993, The American journal of tropical medicine and hygiene.

[95]  F. Lunel,et al.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of Experimental Medicine.

[96]  B. Lowe,et al.  Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. , 2001, Blood.

[97]  J. Hoffmann,et al.  Toll signaling: the TIReless quest for specificity , 2003, Nature Immunology.

[98]  J. Roberts,et al.  A retrospective examination of anemia during infection of humans with Plasmodium vivax. , 2003, The American journal of tropical medicine and hygiene.

[99]  Ching Li,et al.  A role for B cells in the development of T cell helper function in a malaria infection in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[100]  B. Monks,et al.  Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.

[101]  A. Pain,et al.  Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells , 1999, Nature.

[102]  J. Hittner,et al.  Differential Regulation of β-Chemokines in Children with Plasmodium falciparum Malaria , 2005, Infection and Immunity.

[103]  M. Deckert,et al.  Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. , 2007, The American journal of pathology.

[104]  B. Lowe,et al.  B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. , 2005, The Journal of infectious diseases.

[105]  R. Schumann,et al.  Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. , 2006, The Journal of infectious diseases.

[106]  A. Kelso,et al.  The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection , 2002, The Journal of experimental medicine.

[107]  A. Taylor-Robinson,et al.  A dichotomous role for nitric oxide in protection against blood stage malaria infection. , 1999, Immunology letters.

[108]  Christl A. Donnelly,et al.  Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.

[109]  Q. Bassat,et al.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial , 2005, The Lancet.